TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive “Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.” July 14, 1995
